Skip to main content
Equibles
NXGL logo

NXGL · Nexgel, Inc.

Track NXGL — free

Use NXGL with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.35 0.00 (-0.28%) At close · Aug 31
Rebalance outlook locked
Going-concern doubt — flagged Aug 17, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These conditions raise substantial doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 17, 2026
Market Cap
$3.43M
Shares
9.75M

Nexgel, Inc. Earnings Call Transcripts

Quarterly earnings calls for Nexgel, Inc. (NXGL), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲426.7% $532,000 −$1.64M '21 Q4 22-03-21 ▲48.3% $396,000 −$1.84M '22 Q1 22-05-12 ▲34.5% $561,000 −$1.03M '22 Q2 22-08-10 ▲69.6% $568,000 −$1.23M '22 Q3 22-11-08 ▼1.7% $523,000 −$648,000 '22 Q4 23-03-27 ▲56.6% $620,000 −$814,000 '23 Q1 23-05-15 ▲108% $1.17M −$695,000 '23 Q2 23-08-14 ▲115% $1.22M −$550,000 '23 Q3 23-11-13 ▲106.7% $1.08M −$1.10M '23 Q4 23-12-31 ▲104.2% $1.27M −$853,000 '24 Q1 24-05-13 ▲23.4% $1.44M −$885,000 '24 Q2 24-08-14 ▲140.8% $2.94M −$693,000 '24 Q3 24-11-14 ▲181.4% $3.04M −$850,000 '24 Q4 25-03-24 ▲121.6% $2.81M −$712,000 '25 Q1 25-05-13 ▲100.3% $2.88M −$665,000 '25 Q2 25-08-12 LATEST ▼0.2% $2.93M −$653,000 '25 Q3 25-11-12
Earnings call
FY25 · Q3
2025-11-12
Nexgel, Inc. (NXGL) Q3 2025 Earnings Call Transcript
Positive tone Contract manufacturing growth iRhythm / Zio ECG partnership AbbVie / restarting device uncertainty
Revenue
$2.93M
▼ 0.2% YoY
Diluted EPS
$-0.08
Gross margin
42.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-12
Nexgel, Inc. (NXGL) Q2 2025 Earnings Call Transcript
Confident tone Contract Manufacturing Growth Consumer Branded Products / Silly George Pipeline and Future Partnerships
Revenue
$2.88M
▲ 100.3% YoY
Diluted EPS
$-0.09
Gross margin
43.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-13
Nexgel, Inc. (NXGL) Q1 2025 Earnings Call Transcript
Confident tone Revenue and growth momentum Consumer product brand expansion Laser hair removal / hydrogel study
Revenue
$2.81M
▲ 121.6% YoY
Diluted EPS
$-0.09
Gross margin
42.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-24
Nexgel, Inc. (NXGL) Q4 2024 Earnings Call
Revenue
$3.04M*
▲ 181.4% YoY
Gross margin
37.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-14
Nexgel, Inc. (NXGL) Q3 2024 Earnings Call Transcript
Confident tone Record Financial Results Laser Hair Removal / Medical Device Pipeline Silly George Brand Growth
Revenue
$2.94M
▲ 140.8% YoY
Diluted EPS
$-0.11
Gross margin
39.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-14
Nexgel, Inc. (NXGL) Q2 2024 Earnings Call Transcript
Confident tone Silly George acquisition STADA / Histasolv product launch AbbVie / RESONIC partnership
Revenue
$1.44M
▲ 23.4% YoY
Diluted EPS
$-0.14
Gross margin
20.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-13
Nexgel, Inc. (NXGL) Q1 2024 Earnings Call Transcript
Confident tone Revenue Growth European Expansion / MDR Compliance Branded Consumer Products
Revenue
$1.27M
▲ 104.2% YoY
Diluted EPS
$-0.14
Gross margin
12.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Nexgel, Inc. (NXGL) Q4 2023 Earnings Call Transcript
Revenue
$1.08M*
▲ 106.7% YoY
Gross margin
-8.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-13
Nexgel, Inc. (NXGL) Q3 2023 Earnings Call Transcript
Revenue
$1.22M
▲ 115% YoY
Diluted EPS
$-0.10
Gross margin
28.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-14
Nexgel, Inc. (NXGL) Q2 2023 Earnings Call Transcript
Revenue
$1.17M
▲ 108% YoY
Diluted EPS
$-0.12
Gross margin
15.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-15
Nexgel, Inc. (NXGL) Q1 2023 Earnings Call Transcript
Revenue
$620,000
▲ 56.6% YoY
Diluted EPS
$-0.15
Gross margin
-9.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-27
Nexgel, Inc. (NXGL) Q4 2022 Earnings Call
Revenue
$523,000*
▼ 1.7% YoY
Gross margin
5.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Nexgel, Inc. (NXGL) Q3 2022 Earnings Call
Revenue
$568,000
▲ 69.6% YoY
Diluted EPS
$-0.22
Gross margin
26.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-10
Nexgel, Inc. (NXGL) Q2 2022 Earnings Call
Revenue
$561,000
▲ 34.5% YoY
Diluted EPS
$-0.19
Gross margin
18.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-12
Nexgel, Inc. (NXGL) Q1 2022 Earnings Call
Revenue
$396,000
▲ 48.3% YoY
Diluted EPS
$-0.33
Gross margin
-5.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-21
Nexgel, Inc. (NXGL) Q4 2021 Earnings Call
Revenue
$532,000*
▲ 426.7% YoY
Gross margin
19.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–16 of 16 earnings calls
Key facts CIK 1468929 CUSIP 65344E107 13F (30d) 23 filings 23 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)